Trials / Completed
CompletedNCT01055353
Evaluation of Target Organs Damage in Hypertensive Patients
Evaluation of Target Organs Damage in Hypertensive Patients Followed in General Practice With no Known Cardiovascular (CV) or Renal Disease, Stratified According to Blood Pressure Control
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,857 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of target organs damage in hypertensive patients with no known cardiovascular (CV) or renal disease, stratified according to level of blood pressure control
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-01-25
- Last updated
- 2011-05-12
Locations
905 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01055353. Inclusion in this directory is not an endorsement.